Advances in pharmaceutical sciences are continually shaping the future of drug development, delivery, and patient care. Innovations in biotechnology, nanotechnology, and biomaterials are leading to the creation of more effective, targeted, and personalized therapies. Nanoparticle-based drug delivery systems, for example, allow for precise targeting of drugs to specific cells or tissues, minimizing side effects and improving therapeutic outcomes. In addition, advancements in biologics and biosimilars are offering new treatment options for diseases that were once difficult to treat, such as certain cancers and autoimmune disorders. The integration of AI and machine learning into pharmaceutical research has accelerated drug discovery, allowing for faster identification of promising drug candidates and optimizing clinical trials. Furthermore, the development of 3D printing technologies is opening new possibilities for personalized medications, enabling tailored drug formulations based on individual patient needs. These advances in pharmaceutical sciences are transforming healthcare by improving the efficacy, safety, and accessibility of treatments.
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil